Kisspeptin, sexual desire and anxiety
A reproductive signal entering the territory of attraction is an intriguing turn. The idea of a general mood benefit seems a stretch to me.
Attraction in the scanner
A study using visual and olfactory cues of attraction in men found enhanced activity in brain regions involved in sexual behavior after kisspeptin administration. The largest effects occurred in men who reported lower sexual quality of life. That connection between a measured brain response and reported experience gives the experiment a particularly interesting edge.
The route from a reproductive signal to attraction surprises me. Brain imaging can locate changes in processing, while reported experience asks a different question about what those changes feel like. The appeal lies in putting those observations together without treating a scan as a complete account of a person's sexual life.
Men with hypoactive sexual desire disorder
The randomized, double-blind crossover trial in 32 men with hypoactive sexual desire disorder examined sexual-processing networks, penile tumescence and reported desire. Tumescence means the physical swelling associated with arousal. Kisspeptin-54 modulated the brain networks, increased tumescence by up to 56% over placebo and heightened self-reported sexual desire.
That last phrase, self-reported desire, matters to me. The experiment included an account of experience alongside the physical and imaging measures. The percentage refers specifically to tumescence, and the qualifier is 'up to'; carrying it over to desire as a percentage improvement would misdescribe the result. The trial concerns the men studied during the experiment. An enduring change in daily sexual well-being remains a further question.
Anxiety and food intake
A 2025 crossover trial in 95 participants, including 63 men and 32 women, found that kisspeptin-54 increased LH without significantly altering state anxiety, cortisol, blood pressure or heart rate versus placebo. I welcome a result that gives anxiety its own measurement. It prevents a reproductive hormone response from absorbing every nearby idea about feeling better.
There is a similar separation in the food-intake study in women with overweight or obesity. LH rose, confirming biological activity, while self-rated hunger and objectively measured food intake did not change versus vehicle. Together these experiments make the brain story more selective. Sexual processing, anxiety and hunger remain distinct outcomes in distinct populations.
That selective account has my vote. It leaves room for an interesting result in sexual desire while requiring a separate answer about anxiety or appetite. The discovery history shows how surprising the kisspeptin story can be; surprise is already a sufficient reason to follow it.